• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EKOS CORPORATION EKOSONIC ENDOVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EKOS CORPORATION EKOSONIC ENDOVASCULAR CATHETER Back to Search Results
Model Number UNKNOWN
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Appropriate Term/Code Not Available (3191)
Patient Problem Pulmonary Embolism (1498)
Event Date 07/31/2019
Event Type  Injury  
Manufacturer Narrative
The site documented that the patient had a recurrent pe.The primary investigator (pi) assessed this event as not related to the interventional procedure, ekos system, or thrombolytic and probably related to anticoagulant drug.The medical monitor (mm) assessed the sae as probably related to interventional procedure and ekos system and not related to thrombolytic and anticoagulants drugs.There were no device malfunctions documented.The event was not reported to ekos at the time it occurred.While the medical monitor reassessed the sae of recurrent pe and determined that it was related to the ekos device and procedure, a review of source documents demonstrated that the patient had been discharged home after the initial pe on (b)(6) 2019.Doppler studies performed on (b)(6) 2019 revealed dvt in the right lower extremity.Btg believes the recurrent pe was related to the dvt and anticoagulation and not the ekos device, however this event is being reported based on the independent medical monitor's assessment.No additional information will be available.
 
Event Description
Subject (b)(6) is a patient enrolled in the (b)(6) study.This patient is a (b)(6) male.The patient was treated for a bilateral pe on (b)(6) 2019.It was reported the patient was diagnosed with dvt and recurrent pe on (b)(6) 2019 and was classified as a serious adverse event (sae).It is not known what intervention was performed to treat the recurrent pe.The source documents states that there were no complications during the procedure on (b)(6) 2019.The primary investigator (pi) assessed this event as not related to the interventional procedure, ekos system, or thrombolytic and probably related to anticoagulant drug.On 26 september 2019, btg became aware that the medical monitor (mm) reassessed the sae as probably related to interventional procedure and ekos system and not related to thrombolytic and anticoagulants drugs.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EKOSONIC ENDOVASCULAR CATHETER
Type of Device
EKOSONIC ENDOVASCULAR CATHETER
Manufacturer (Section D)
EKOS CORPORATION
11911 north creek parkway s
bothell WA 98011 8809
Manufacturer (Section G)
EKOS CORPORATION
11911 north creek parkway
bothell WA 98011 8809
Manufacturer Contact
sandara bausback-aballo
300 conshohocken state rd,
300 four falls corporate ctr.
west conshohocken, PA 19428-2998
6103311537
MDR Report Key9240147
MDR Text Key177642038
Report Number3001627457-2019-00036
Device Sequence Number1
Product Code KRA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K182324
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type study
Reporter Occupation Physician
Type of Report Initial
Report Date 09/26/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/26/2019
Initial Date FDA Received10/25/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age66 YR
-
-